Company
Headquarters: Toronto, ON, Canada
CEO: Mr. George Achilleos
| Company | Market Cap (USD) |
|---|---|
| GE HealthCare | $37.81 B |
| Veeva Systems Inc. | $36.08 B |
| M3, Inc. | $11.14 B |
| Change Healthcare Inc. | $9.03 B |
| Pro Medicus Limited | $8.96 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $968.50 B |
| Johnson & Johnson | $499.57 B |
| AbbVie | $405.28 B |
| Roche | $332.12 B |
| UnitedHealth Group | $304.72 B |
Nurosene Inc., a technology-driven wellness company, focuses on developing a line of proprietary nutraceuticals in Canada. It develops nutraceuticals, including Nuro Drive, a product to enhance physical and cognitive energy levels; Nuro Restore, a product to improve sleep, as well as reduce stress, and pain and inflammation. The company is also developing a virtual care mobile application to provide continuous support to those suffering from mental health issues. Nurosene Inc. was incorporated in 2019 and is headquartered in Toronto, Canada.
Nurosene Health, Inc. has the following listings and related stock indices.
Stock: CSE: MEND